New Drug Slows the Progression of Alzheimer's by 50%
The treatment also cut tau protein levels and doubled time in early disease stages, researchers said.
8 Articles
8 Articles
Alzheimer’s jab ‘halves rate of cognitive decline’ in major trial
Patients given the injections showed 54 per cent less decline on a test of memory and thinking over almost two years
Alzheimer’s brain decline slashed in half by ‘thrilling’ new twice-a-year drug: trial
A new drug may prove to be a game changer in Alzheimer’s research following the results of an incredible trial. Patients administered low-dose diranersen injections showed 54% less decline on a test of memory and thinking over nearly two years, suggesting the experimental treatment could slow the…
A new injection method has been developed that has given the strongest results to date in the treatment of Alzheimer's disease. The treatment, called “diranersen,” administered only twice a year and using gene-silencing technology, reduced the decline in patients' memory and thinking skills by 54 percent.
Coverage Details
Bias Distribution
- 60% of the sources lean Left
Factuality
To view factuality data please Upgrade to Premium








